Literature DB >> 25032955

The role of estrogen receptor β in prostate cancer.

Paraskevi Christoforou1, Panagiotis F Christopoulos1, Michael Koutsilieris1.   

Abstract

Although androgen receptor (AR) signaling is the main molecular tool regulating growth and function of the prostate gland, estrogen receptor β (ERβ) is involved in the differentiation of prostatic epithelial cells and numerous antiproliferative actions on prostate cancer cells. However, ERβ splice variants have been associated with prostate cancer initiation and progression mechanisms. ERβ is promising as an anticancer therapy and in the prevention of prostate cancer. Herein, we review the recent experimental findings of ERβ signaling in the prostate.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25032955      PMCID： PMC4212017          DOI： 10.2119/molmed.2014.00105

Source DB:  PubMed          Journal:  Mol Med        ISSN： 1076-1551            Impact factor:   6.354


  81 in total

Review 1.  ERbeta: recent understanding of estrogen signaling.

Authors:  Nobuhiro Sugiyama; Rodrigo P A Barros; Margaret Warner; Jan-Ake Gustafsson
Journal:  Trends Endocrinol Metab       Date:  2010-06-18       Impact factor: 12.015

Review 2.  The pros and cons of phytoestrogens.

Authors:  Heather B Patisaul; Wendy Jefferson
Journal:  Front Neuroendocrinol       Date:  2010-03-27       Impact factor: 8.606

Review 3.  Estrogen receptor β.

Authors:  Mamoun Younes; Naoko Honma
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

4.  17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.

Authors:  A M Miró; J Sastre-Serra; D G Pons; A Valle; P Roca; J Oliver
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-21       Impact factor: 4.292

5.  Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.

Authors:  Donatella Dondi; Margherita Piccolella; Andrea Biserni; Sara Della Torre; Balaji Ramachandran; Alessia Locatelli; Paola Rusmini; Daniela Sau; Donatella Caruso; Adriana Maggi; Paolo Ciana; Angelo Poletti
Journal:  Endocr Relat Cancer       Date:  2010-07-28       Impact factor: 5.678

6.  Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression.

Authors:  Olivier Celhay; Mokrane Yacoub; Jacques Irani; Bertrand Dore; Olivier Cussenot; Gaelle Fromont
Journal:  J Urol       Date:  2010-09-17       Impact factor: 7.450

7.  Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Authors:  V Rossi; G Bellastella; C De Rosa; C Abbondanza; D Visconti; L Maione; P Chieffi; F Della Ragione; D Prezioso; A De Bellis; A Bellastella; A A Sinisi
Journal:  J Cell Physiol       Date:  2011-05       Impact factor: 6.384

8.  Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

Authors:  C Z Cotrim; V Fabris; M L Doria; K Lindberg; J-Å Gustafsson; F Amado; C Lanari; L A Helguero
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

Review 9.  Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Authors:  Melanie J Grubisha; Donald B DeFranco
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

10.  Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.

Authors:  Yuet-Kin Leung; Hung-Ming Lam; Shulin Wu; Dan Song; Linda Levin; Liang Cheng; Chin-Lee Wu; Shuk-Mei Ho
Journal:  Endocr Relat Cancer       Date:  2010-06-25       Impact factor: 5.678
View more
  24 in total

Review 1.  From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?

Authors:  Victoria Shang Wu; Noriko Kanaya; Chiao Lo; Joanne Mortimer; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2015-05-18       Impact factor: 4.292

2.  Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression.

Authors:  Paul Mak; Jiarong Li; Sanjoy Samanta; Cheng Chang; D Joseph Jerry; Roger J Davis; Irwin Leav; Arthur M Mercurio
Journal:  Cell Rep       Date:  2015-03-26       Impact factor: 9.423

3.  Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.

Authors:  Patrick M Kelly; Niall O Keely; Sandra A Bright; Bassem Yassin; Gloria Ana; Darren Fayne; Daniela M Zisterer; Mary J Meegan
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

Review 4.  Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.

Authors:  A Fucic; A Aghajanyan; Z Culig; N Le Novere
Journal:  Pathol Oncol Res       Date:  2018-09-16       Impact factor: 3.201

5.  Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.

Authors:  Dorota Jędroszka; Magdalena Orzechowska; Raneem Hamouz; Karolina Górniak; Andrzej K Bednarek
Journal:  PLoS One       Date:  2017-12-04       Impact factor: 3.240

Review 6.  Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications.

Authors:  Erika Di Zazzo; Giovanni Galasso; Pia Giovannelli; Marzia Di Donato; Gabriella Castoria
Journal:  Front Oncol       Date:  2018-01-18       Impact factor: 6.244

7.  The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells.

Authors:  Shaneabbas Raza; Megan Meyer; Casey Goodyear; Kimberly D P Hammer; Bin Guo; Othman Ghribi
Journal:  Cancer Cell Int       Date:  2017-05-11       Impact factor: 5.722

8.  Transcriptomic analysis of castration, chemo-resistant and metastatic prostate cancer elucidates complex genetic crosstalk leading to disease progression.

Authors:  Sayani Mukherjee; C Sudandiradoss
Journal:  Funct Integr Genomics       Date:  2021-06-29       Impact factor: 3.410

Review 9.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

Review 10.  Oestrogens and oestrogen receptors in prostate cancer.

Authors:  Karolina Kowalska; Agnieszka Wanda Piastowska-Ciesielska
Journal:  Springerplus       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.